{"id":"https://openalex.org/W4280654366","doi":"https://doi.org/10.21115/jbes.v14.n1.p56-62","title":"Atualiza\u00e7\u00e3o do custo-efetividade por resposta de adalimumabe, etanercepte, guselcumabe, infliximabe, ixequizumabe, secuquinumabe e ustequinumabe no tratamento de psor\u00edase em placas moderada a grave sob a perspectiva do Sistema de Sa\u00fade Suplementar brasile","display_name":"Atualiza\u00e7\u00e3o do custo-efetividade por resposta de adalimumabe, etanercepte, guselcumabe, infliximabe, ixequizumabe, secuquinumabe e ustequinumabe no tratamento de psor\u00edase em placas moderada a grave sob a perspectiva do Sistema de Sa\u00fade Suplementar brasile","alternate_titles":["An update of a cost-effectiveness per response of adalimumab, etanercept, guselcumab, infliximab, ixekizumab, secukinumab and ustekinumab for treatment of moderate to severe plaque psoriasis from the perspective of the Brazilian Supplementary Health Syste"],"publication_year":2022,"publication_date":"2022-04-20","ids":{"openalex":"https://openalex.org/W4280654366","doi":"https://doi.org/10.21115/jbes.v14.n1.p56-62"},"language":"pt","primary_location":{"id":"doi:10.21115/jbes.v14.n1.p56-62","doi":"https://doi.org/10.21115/jbes.v14.n1.p56-62","is_oa":true,"landing_page_url":"http://doi.org/10.21115/jbes.v14.n1.p56-62","pdf_url":"https://doi.org/10.21115/jbes.v14.n1.p56-62","source":{"id":"https://openalex.org/S4210220290","display_name":"Jornal Brasileiro de Economia da Sa\u00fade","issn_l":"2175-2095","issn":["2175-2095","2359-1641"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jornal Brasileiro de Economia da Sa\u00fade","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4280654366"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.21115/jbes.v14.n1.p56-62","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066299884","display_name":"Alexander von Reininghaus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexander Reininghaus","raw_affiliation_strings":[". Janssen-Cilag Farmac\u00eautica, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Janssen-Cilag Farmac\u00eautica, S\u00e3o Paulo, SP, Brasil","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rafael Gomes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I61722147","display_name":"Universidade do Vale do Rio dos Sinos","ror":"https://ror.org/05ctmmy43","country_code":"BR","type":"education","lineage":["https://openalex.org/I61722147"]}],"countries":["BR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rafael Gomes","raw_affiliation_strings":["Universidade do Vale do Rio dos Sinos (Unisinos) , S\u00e3o Leopoldo , RS , Brasil",". Janssen-Cilag Farmac\u00eautica, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade do Vale do Rio dos Sinos (Unisinos) , S\u00e3o Leopoldo , RS , Brasil","institution_ids":["https://openalex.org/I61722147"]},{"raw_affiliation_string":". Janssen-Cilag Farmac\u00eautica, S\u00e3o Paulo, SP, Brasil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049902435","display_name":"Bernardo Rodrigues Pires","orcid":"https://orcid.org/0000-0002-7449-6825","observed_orcids":["https://orcid.org/0000-0002-7449-6825"]},"institutions":[{"id":"https://openalex.org/I61722147","display_name":"Universidade do Vale do Rio dos Sinos","ror":"https://ror.org/05ctmmy43","country_code":"BR","type":"education","lineage":["https://openalex.org/I61722147"]}],"countries":["BR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bernardo Pires","raw_affiliation_strings":["Universidade do Vale do Rio dos Sinos (Unisinos) , S\u00e3o Leopoldo , RS , Brasil",". Janssen-Cilag Farmac\u00eautica, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade do Vale do Rio dos Sinos (Unisinos) , S\u00e3o Leopoldo , RS , Brasil","institution_ids":["https://openalex.org/I61722147"]},{"raw_affiliation_string":". Janssen-Cilag Farmac\u00eautica, S\u00e3o Paulo, SP, Brasil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106182308","display_name":"Juares Bianco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Juares Bianco","raw_affiliation_strings":[". Cerner Enviza, S\u00e3o Paulo, SP, Brasil","Boehringer-Ingelheim, Janssen, Leo Pharma, Lilly, Novartis","Lilly","UCB. Rafael Romiti contribuiu com","recebeu honor\u00e1rios como palestrante e por participa\u00e7\u00e3o em advisory board, bem como pesquisa cl\u00ednica dos laborat\u00f3rios AbbVie, Amgen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Cerner Enviza, S\u00e3o Paulo, SP, Brasil","institution_ids":[]},{"raw_affiliation_string":"Boehringer-Ingelheim, Janssen, Leo Pharma, Lilly, Novartis","institution_ids":[]},{"raw_affiliation_string":"Lilly","institution_ids":[]},{"raw_affiliation_string":"UCB. Rafael Romiti contribuiu com","institution_ids":[]},{"raw_affiliation_string":"recebeu honor\u00e1rios como palestrante e por participa\u00e7\u00e3o em advisory board, bem como pesquisa cl\u00ednica dos laborat\u00f3rios AbbVie, Amgen,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086624452","display_name":"Renato Mantelli Picoli","orcid":"https://orcid.org/0000-0001-8154-6467","observed_orcids":["https://orcid.org/0000-0001-8154-6467"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Renato Picoli","raw_affiliation_strings":[". Cerner Enviza, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Cerner Enviza, S\u00e3o Paulo, SP, Brasil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048991062","display_name":"H. P. dos Santos","orcid":"https://orcid.org/0000-0002-7587-7398","observed_orcids":["https://orcid.org/0000-0002-7587-7398"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henrique Santos","raw_affiliation_strings":[". Cerner Enviza, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Cerner Enviza, S\u00e3o Paulo, SP, Brasil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076654873","display_name":"Gleison Vieira Duarte","orcid":"https://orcid.org/0000-0003-4160-5447","observed_orcids":["https://orcid.org/0000-0003-4160-5447"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gleison Duarte","raw_affiliation_strings":[". Instituto Bahiano de Imunoterapias (IBIS), Salvador, BA, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Instituto Bahiano de Imunoterapias (IBIS), Salvador, BA, Brasil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080979879","display_name":"Ricardo Romiti","orcid":"https://orcid.org/0000-0003-0165-3831","observed_orcids":["https://orcid.org/0000-0003-0165-3831"]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]},{"id":"https://openalex.org/I4210145268","display_name":"Hospital das Cl\u00ednicas da Faculdade de Medicina da Universidade de S\u00e3o Paulo","ror":"https://ror.org/03se9eg94","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210145268"]}],"countries":["BR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ricardo Romiti","raw_affiliation_strings":[". Departamento de Dermatologia do Hospital das Cl\u00ednicas da Universidade de S\u00e3o Paulo (USP), S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Departamento de Dermatologia do Hospital das Cl\u00ednicas da Universidade de S\u00e3o Paulo (USP), S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I17974374","https://openalex.org/I4210145268"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101515708","display_name":"Andr\u00e9 Rezende Dessimoni Carvalho","orcid":"https://orcid.org/0000-0001-9821-0812","observed_orcids":["https://orcid.org/0000-0001-9821-0812"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andr\u00e9 Carvalho","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"1","first_page":"56","last_page":"62"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9140999913215637,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9140999913215637,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.07639999687671661,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9100000262260437},{"id":"https://openalex.org/keywords/moderate-to-severe-plaque-psoriasis","display_name":"moderate-to-severe plaque psoriasis","score":0.8740000128746033},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.5950000286102295},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8040000200271606},{"id":"https://openalex.org/keywords/cost-per-response","display_name":"cost per response","score":0.7559999823570251},{"id":"https://openalex.org/keywords/pasi-90","display_name":"PASI 90","score":0.9120000004768372},{"id":"https://openalex.org/keywords/ixekizumab","display_name":"ixekizumab","score":0.9789999723434448},{"id":"https://openalex.org/keywords/ustekinumab","display_name":"ustekinumab","score":0.9509999752044678},{"id":"https://openalex.org/keywords/secukinumab","display_name":"secukinumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.968999981880188},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.8479999899864197},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.9940000176429749},{"id":"https://openalex.org/keywords/supplementary-health-insurance","display_name":"supplementary health insurance","score":0.625},{"id":"https://openalex.org/keywords/treatment-selection","display_name":"treatment selection","score":0.5130000114440918}],"concepts":[{"id":"https://openalex.org/C15708023","wikidata":"https://www.wikidata.org/wiki/Q80083","display_name":"Humanities","level":1,"score":0.44907480478286743},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4147486090660095},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3491564393043518},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.19642698764801025}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.21115/jbes.v14.n1.p56-62","doi":"https://doi.org/10.21115/jbes.v14.n1.p56-62","is_oa":true,"landing_page_url":"http://doi.org/10.21115/jbes.v14.n1.p56-62","pdf_url":"https://doi.org/10.21115/jbes.v14.n1.p56-62","source":{"id":"https://openalex.org/S4210220290","display_name":"Jornal Brasileiro de Economia da Sa\u00fade","issn_l":"2175-2095","issn":["2175-2095","2359-1641"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jornal Brasileiro de Economia da Sa\u00fade","raw_type":"journal-article"},{"id":"pmh:oai:ojs2.revista.jbes.com.br:article/85","doi":null,"is_oa":true,"landing_page_url":"https://www.jbes.com.br/index.php/jbes/article/view/85","pdf_url":"https://www.jbes.com.br/index.php/jbes/article/download/85/69","source":{"id":"https://openalex.org/S4210220290","display_name":"Jornal Brasileiro de Economia da Sa\u00fade","issn_l":"2175-2095","issn":["2175-2095","2359-1641"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2175-2095","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.21115/jbes.v14.n1.p56-62","doi":"https://doi.org/10.21115/jbes.v14.n1.p56-62","is_oa":true,"landing_page_url":"http://doi.org/10.21115/jbes.v14.n1.p56-62","pdf_url":"https://doi.org/10.21115/jbes.v14.n1.p56-62","source":{"id":"https://openalex.org/S4210220290","display_name":"Jornal Brasileiro de Economia da Sa\u00fade","issn_l":"2175-2095","issn":["2175-2095","2359-1641"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jornal Brasileiro de Economia da Sa\u00fade","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320338413","display_name":"Cilag","ror":"https://ror.org/02fe4h741"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4280654366.pdf","grobid_xml":"https://content.openalex.org/works/W4280654366.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1829772998","https://openalex.org/W1997690403","https://openalex.org/W2060836363","https://openalex.org/W2066227212","https://openalex.org/W2121222045","https://openalex.org/W2137096780","https://openalex.org/W2599614959","https://openalex.org/W2755835629","https://openalex.org/W2781078917","https://openalex.org/W2895775669","https://openalex.org/W2908033840","https://openalex.org/W2912058252","https://openalex.org/W2936770744","https://openalex.org/W2944389217","https://openalex.org/W3009872190","https://openalex.org/W3012050575","https://openalex.org/W3012569855","https://openalex.org/W3024308413","https://openalex.org/W3028355101","https://openalex.org/W3029724060","https://openalex.org/W3032990333","https://openalex.org/W3036055555","https://openalex.org/W3037060742","https://openalex.org/W3149331822","https://openalex.org/W3203680444","https://openalex.org/W4237432556"],"related_works":["https://openalex.org/W2936770744","https://openalex.org/W2521908707","https://openalex.org/W4388508736","https://openalex.org/W2954535872","https://openalex.org/W7216877676","https://openalex.org/W4252038558","https://openalex.org/W2810927735","https://openalex.org/W2905752141","https://openalex.org/W7134826151","https://openalex.org/W4412975556"],"abstract_inverted_index":{"Objetivo:":[0],"Os":[1,92,130],"agentes":[2,45],"biol\u00f3gicos":[3,46],"representam":[4],"um":[5],"grande":[6],"avan\u00e7o":[7],"no":[8,50,235,245],"tratamento":[9,124,236],"da":[10,59,88,121,143,145,237],"psor\u00edase":[11,49,238],"em":[12,56,239],"placas":[13,240],"moderada":[14,241],"a":[15,29,77,104,109,209,230,242],"grave.":[16],"No":[17,184],"entanto,":[18],"varia\u00e7\u00f5es":[19],"de":[20,52,62,69,79,84,106,127,140,147,151,153,155,196,205,213],"efic\u00e1cia,":[21],"seguran\u00e7a":[22],"e":[23,54,86,108,116,182],"custos":[24,131],"dos":[25,44,132],"tratamentos":[26,133],"podem":[27],"dificultar":[28],"escolha":[30],"do":[31,123,149,211,216],"agente":[32,194],"terap\u00eautico.":[33],"Este":[34],"estudo":[35],"teve":[36],"como":[37],"objetivo":[38],"atualizar":[39],"o":[40,97,159,162,189,193,202,218,221],"custo":[41,70,80,168,223],"por":[42,71,169,176,224],"resposta":[43,72,170,225],"dispon\u00edveis":[47],"para":[48,75,96,167],"ROL":[51],"Procedimentos":[53],"Eventos":[55],"Sa\u00fade":[57,63,214],"(ROL)":[58],"Ag\u00eancia":[60],"Nacional":[61],"Suplementar":[64,215],"(ANS).":[65],"M\u00e9todos:":[66],"Uma":[67],"an\u00e1lise":[68,120],"foi":[73,117],"utilizada":[74],"avaliar":[76],"raz\u00e3o":[78],"pelo":[81],"desfecho":[82],"\u00cdndice":[83],"Gravidade":[85],"\u00c1rea":[87],"Psor\u00edase":[89],"(PASI)":[90],"90.":[91],"resultados":[93],"foram":[94,134],"apresentados":[95],"primeiro":[98],"ano":[99,160],"(ano":[100],"I),":[101],"que":[102],"compreende":[103],"fase":[105,110],"indu\u00e7\u00e3o":[107],"manuten\u00e7\u00e3o":[111],"at\u00e9":[112],"completar":[113],"52":[114],"semanas":[115],"realizada":[118],"uma":[119],"efetividade":[122],"num":[125],"cen\u00e1rio":[126,185],"or\u00e7amento":[128,187],"fixo.":[129],"calculados":[135],"com":[136,186,198,232],"base":[137],"nos":[138],"pre\u00e7os":[139],"f\u00e1brica":[141],"(PF18%)":[142],"Tabela":[144],"C\u00e2mara":[146],"Regula\u00e7\u00e3o":[148],"Mercado":[150],"Medicamentos":[152],"junho":[154],"2021.":[156],"Resultados:":[157],"Para":[158],"I,":[161],"guselcumabe":[163,190,219],"apresentou":[164,220],"melhor":[165,222,233],"resultado":[166],"(R$":[171],"130.467)":[172],"PASI":[173,226],"90,":[174,227],"seguido":[175],"ixequizumabe,":[177],"ustequinumabe,":[178],"secuquinumabe,":[179],"adalimumabe,":[180],"infliximabe":[181],"etanercepte.":[183],"fixo,":[188],"demonstrou":[191],"ser":[192],"capaz":[195],"tratar":[197],"sucesso":[199],"(PASI":[200],"90)":[201],"maior":[203],"n\u00famero":[204],"pacientes,":[206],"Conclus\u00e3o:":[207],"Sob":[208],"perspectiva":[210],"Sistema":[212],"Brasil,":[217],"sendo,":[228],"assim,":[229],"terapia":[231],"custo-efetividade":[234],"grave":[243],"dispon\u00edvel":[244],"ROL.":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4280654366","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2022-05-22T00:00:00"}
